Shares of 3M Co. surged Wednesday after the maker of consumer, industrial and healthcare products said the U.S. Department of Defense’s records show that the “vast majority” of claimants in litigation...
Tag: Clothing/Textiles
Novavax Says ‘Substantial Doubt’ Around Its Continuing Operations
Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this year. In a quarterly earnings report issued after the market c...
Here are five companies to pick if Goldman Sachs is right about the stock market being flat in 2023
Hearts, flowers and CPI data. Get ready for Tuesday. And hell hath no fury like a disappointed Wall Street. The last time CPI let the markets down — last September — stocks melted down like chocolate....
15 dividend stocks whose 5% to 10% yields appear safe in 2023 and 2024 by this analysis
Corrected dividend stock screen table, because Hanesbrands had eliminated its dividend on Feb. 2. See note above table. If you are investing in dividend stocks, the last thing you want to see is a com...
North Face parent blows past Wall Street quarterly expectations, cuts dividend
Shares of VF Corp. rallied more than 6% in the extended session Tuesday after the maker of The North Face jackets and Jansport backpacks, among other outdoor apparel, reported third-quarter results th...
The next few days may reveal whether investors have been riding one big suckers rally, says this strategist.
Stocks are off to a weaker start as caution grips investors following Friday’s monster jobs beat. While subject to revisions, that 517,000 surge in U.S. jobs may have shredded hopes among some that th...
Hanesbrands stock plunges toward biggest selloff in 15 years after relatively high dividend eliminated, warning of a Q1 loss
Shares of Hanesbrands Inc. HBI, -27.38% plummeted 20.7% in morning trading Thursday, putting them on track for the worst one-day performance in nearly 15 years, after the T-shirt and underwear seller ...
Blackstone Stock Is a Good Investment, Even in a Downbeat Economy
These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...
China’s Big Comeback Is Just Getting Started. How to Play It.
Talk about a comeback. As China abandons policies that stifled economic growth for the past three years, investors have sent the country’s stocks soaring—up more than 50% since October. The rally migh...
CureVac Stock Just Got Upgraded. It’s Now a Competitor in mRNA Vaccines.
CureVac is ready to compete in the big leagues with its vaccines, according to a UBS analyst who says the soaring stock has more room to rise. UBS analyst Eliana Merle upgraded the shares (ticker: CVA...
One of Wall Street’s biggest bulls last year says he’s learned his lesson and isn’t chasing stocks right now
The young new year has been all about reversion to the mean. Take the ARK Innovation ETF ARKK, -2.94% — Cathie Wood’s flagship fund of mostly unprofitable tech companies has stormed 19% higher in 2023...
Dow drops over 600 points, posts worst day of year after weak economic data, hawkish Fed remarks erase inflation cheer
U.S. stock indexes finished sharply lower on Wednesday, with both the Dow Jones Industrial Average and the S&P 500 index booking their worst day in over a month, after data on falling retail sales...
Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.
Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...
Hanesbrands stock rallies on hiked outlook
Hanesbrand Inc.’s HBI, -1.00% stock rallied in the extended session Thursday after the apparel company hiked its outlook, and announced a search for a new chief financial officer. Hanesbrands shares m...
Fed’s Powell won’t stop rate hikes until he ‘terrifies’ the wealthiest of investors, says this CIO
Investors are waking up to a whiff of positivity where stocks are concerned for Monday, after last week’s first gain in five that was prompted by weak wage growth Alongside a bleak Institute for Suppl...
European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas
European drugmakers on Monday announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums. Anglo-Swedish AstraZeneca AZN, +1.42% AZN, -1.26% said it’s pay...
Nike, FedEx, Micron, General Mills, and Other Stocks for Investors to Watch This Week
A bevy of economic data and several notable companies reporting will keep investors busy this week, before things slow down for the holidays. On Tuesday, Nike FedEx and General Mills release quarterl...
FedEx and Nike earnings will hold vital hints on holiday-shopping strength
After investors raced for the exits following their last earnings reports, package-deliverer FedEx Corp. and athletic-gear maker Nike Inc. will try it again. And they’ll offer important reads on deman...
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA technology and the outlook for a combined flu/COVID vaccine and oncology vaccines tha...
Vanguard sees a recession in 2023 — and one ‘silver lining’ for investors
The last 12 months was a year of fast-rising inflation, fast-rising interest rates and fast-rising questions about a future recession. Prices went up while stock markets and savings account balances w...
The 20 worst U.S. stocks in February: the biggest loser dropped 35%
Updated with month-end prices. The euphoria of January reversed in February, with broad declines for stocks across the board as interest rates continued to rise. Bond interest rates are more attractiv...